ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: osteoporosis

ACR Opposes DXA Reimbursement Cuts

Kelly Tyrrell  |  October 31, 2016

The Centers for Medicare and Medicaid Services (CMS) plans to significantly reduce reimbursement for dual-energy X-ray absorptiometry (DXA),—used to measure bone density, diagnose osteoporosis and help prevent fractures—performed as a hospital outpatient service in the 2017 Hospital Outpatient Prospective Payment System (HOPPS). If finalized, by 2023 it will cut payment for the DXA testing by 37%….

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:bipartisan bill H.R.2461dual-energy x-ray absorptiometryDXAreimbursement cuts

New Treatment Guidelines to Be Presented at the 2016 ACR/ARHP Annual Meeting

Thomas R. Collins  |  October 27, 2016

Two sets of guidelines—one on managing anti-rheumatic drugs perioperatively for patients undergoing total hip and knee replacements, and another that updates glucocorticoid-induced osteoporosis prevention and treatment strategies—will be featured in sessions at the 2016 ACR/ARHP Annual Meeting this month. The Sessions Sunday, Nov. 13, 2:30–3:30 p.m.: Glucocorticoid-Induced Osteoporosis Prevention and Treatment: A New ACR Clinical…

Filed under:ConditionsOsteoarthritis and Bone DisordersProfessional Topics Tagged with:2016 ACR/ARHP Annual Meetinganti-rheumatic drugsBiologicsGlucocorticoid-Induced OsteoporosisOsteoporosistreatment guidelines

Denosumab Linked to Rebound-Associated Fractures in Nine Patients

Reuters Staff  |  October 21, 2016

NEW YORK (Reuters Health)—Patients can develop rebound-associated vertebral fractures after stopping denosumab, a new report of nine cases shows. All of the patients were considered to be at low risk of fracture, and the fractures occurred within nine to 16 months of their last injection, Dr. Olivier Lamy and colleagues from Lausanne University Hospital in Switzerland…

Filed under:ConditionsOsteoarthritis and Bone DisordersProfessional Topics Tagged with:bone mineral density (BMD)bone turnover rebound (BTR)denosumabFracturesOsteoporosisosteoporosis treatmentsvertebral fracture

Proton Pump Inhibitor Use May Be Linked to Bone Mineral Density

Michele B. Kaufman, PharmD, BCGP  |  October 19, 2016

The use of proton pump inhibitors may lead to changes in bone mineral density and an increased risk of developing osteoporosis…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:bone mineral density (BMD)denosumabGlucocorticoid-Induced OsteoporosisGlucocorticoidsOsteoporosisproton pump inhibitor (PPI)

Rheumatologists on the Move, October 2016

Ann-Marie Lindstrom  |  October 10, 2016

Dr. Amanda King Elected President of Caribbean Association for Rheumatology The Caribbean Association for Rheumatology (CAR) elected Amanda King, MBBS(UWI), MRCP(UK), FRCP(Glas.), president during the 7th Annual CAR Scientific Meeting this summer. This year’s CAR meeting concentrated on education for general practitioners, because there are still some islands without a rheumatologist. She is the only rheumatologist…

Filed under:Career Development Tagged with:appointmentsAwardsCareerpromotionrheumatologist

Rheumatologist, Jazz Guitarist Dr. Alan Schenk Connects with Patients, Colleagues by Playing Music

Linda Childers  |  October 10, 2016

It’s not uncommon for a new patient to arrive at the medical offices of Alan Schenk, MD, in Laguna Woods, Calif., and immediately ask him about his musical career. In addition to being a board-certified rheumatologist for the past 32 years, Dr. Schenk is also an accomplished acoustic jazz guitarist and mandolin player. Music First “I…

Filed under:Profiles Tagged with:Dr. Alan Schenkhobbypatient carerheumatologist

Preceptorships, Mentors Steer Rheumatology

From the College  |  October 10, 2016

Brian Le, MD, a rheumatology fellow at the Medical College of Georgia at Augusta University (MCG), credits an excellent mentor and two Rheumatology Research Foundation preceptorships with guiding his career toward rheumatology. “Working with Dr. Laura Carbone has opened up a lot of doors for me,” says Dr. Le. “I wouldn’t have such a great relationship with…

Filed under:Career DevelopmentFrom the CollegeResearch Rheum Tagged with:Career developmentDr. Brian Lefellowmedical studentMentorPreceptorshipRheumatology Research Foundation

Rheumatoid Arthritis Patient Shares Lessons Learned from Breaking Leg in a Fall

Sarah Troxell, RN, BSN  |  September 8, 2016

Humpty Dumpty sat on a wall Humpty Dumpty had a great fall All the king’s horses and all the king’s men Couldn’t put Humpty together again. —Mother Goose I feel like a female Humpty Dumpty. Recently I took a great fall, and now I am in the process of being put together again. I was…

Filed under:ConditionsPatient PerspectiveRheumatoid Arthritis Tagged with:outcomepatient careRheumatoid arthritisrheumatologist

FDA Approves Updated Labeling on Risk of Osteonecrosis of the Jaw for Denosumab

Michele B. Kaufman, PharmD, BCGP  |  August 24, 2016

Denosumab’s labeling now says a patient’s risk of developing osteonecrosis of the jaw may increase with prolonged exposure…

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:bonedenosumabFDAFood and Drug AdministrationOsteonecrosisOsteoporosis

GI Side Effects Leading Reason for Bisphosphonate Nonadherence

Reuters Staff  |  July 6, 2016

NEW YORK (Reuters Health)—Gastrointestinal side effects are the most common reason osteoporotic women cite for nonadherence to oral bisphosphonate therapy, according to a new survey. “Our findings highlight the importance of low tolerability to nonadherence with osteoporosis therapy and underlines patients’ poor awareness and suboptimal physicians’ involvement in conveying the importance of this therapy,” Dr….

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:adherencebisphosphonatesgastrointestinalOsteoporosisside effectWomen

  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 59
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences